Broncholyte is clinically proven to be a systematically active agent in the thinning and break down of mucus. It has a rapid onset of action which manifests clinically in increased sputum production evident 2 – 3 days after initiation of therapy. Broncholyte is useful in all forms of tracheobronchitis, emphysema with pulmonary bronchitis, chronic inflammatory pulmonary conditions, bronchiectasis, bronchitis with bronchospasms.